No Difference in Intra-Arterial and Intramuscular Delivery of Autologous Bone Marrow Cells in Patients with Advanced Critical Limb Ischemia
Stem cell therapy has been proposed to be an alternative therapy in patients with critical limb ischemia (CLI), not eligible for endovascular or surgical revascularization. We compared the therapeutic effects of intramuscular (IM) and intra-arterial (IA) delivery of bone marrow cells (BMCs) and inve...
Main Authors: | Andrej Klepanec, Martin Mistrik, Cestmir Altaner, Martina Valachovicova, Ingrid Olejarova, Roman Slysko, Tibor Balazs, Terezia Urlandova, Daniela Hladikova, Branislav Liska, Jan Tomka, Ivan Vulev, Juraj Madaric M.D., Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X636948 |
Similar Items
-
Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bone marrow mononuclear cells.
by: Cestmir Altaner, et al.
Published: (2013-01-01) -
Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemia
by: Juraj Madaric, et al.
Published: (2017-07-01) -
Intramuscular autologous blood therapy - a systematic review of controlled trials
by: Katja Oomen-Welke, et al.
Published: (2019-09-01) -
Suicide Gene Therapy Mediated with Exosomes Produced by Mesenchymal Stem/Stromal Cells Stably Transduced with HSV Thymidine Kinase
by: Andrea Pastorakova, et al.
Published: (2020-04-01) -
Water Jet Technology: Experimental Verification of the Input Factors Variation Influence on the Generated Vibration Levels and Frequency Spectra
by: Stefania Olejarova, et al.
Published: (2021-07-01)